© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
[2018] NSWCATOD 35
NCAT Occupational
2018-02-14
Original judgment source is linked above.
REASONS FOR DECISION
FACTS
Morphine
Jemalong Nursing Records
PARTICULARS OF COMPLAINT 1 1. On 16 February 2015 the practitioner prescribed Endone 5mg (1 tablet x 4 times daily) to Patient A which was not clinically indicated in circumstances where: (a) the practitioner had not consulted with Patient A; [admitted] (b) [particular removed] (c) [particular removed] (d) Patient A was already prescribed Panadol-Osteo for pain management. [Not admitted] 2. On 18 February 2015 the practitioner prescribed a fentanyl transdermal skin patch 50mcg/h to Patient A for night time agitation and chronic osteoarthritis pain which was not clinically indicated in circumstances where: (a) Patient A was narcotic-naïve; [admitted] (b) the practitioner failed to consider potential drug interactions between fentanyl and Patient A's anti-depressant Sertraline; [not admitted] (c) the starting dose was excessive; [admitted] (d) the practitioner failed to consider non-narcotic options for Patient A including: [denied] (i) glucosamine sulphate; (ii) tricyclic anti-depressants; (iii) pregabalin; (iv) physical remedies including massage and physiotherapy; (v) herbal remedies; (e) the practitioner failed to consider transdermal buprenorphine as an alternative and gentler narcotic option for Patient A; [admitted) (f) the practitioner failed to confirm whether Patient A had been administered the prescribed Endone by either: (i) speaking with nursing home staff; [denied] (ii) reviewing Patient A's medical records. [Admitted] 3. On 18 February 2015, following prescription of fentanyl 50mcg/h, the practitioner failed to provide nursing staff with instructions as to observations required in relation to Patient A including to: (a) undertake routine observations including blood pressure, pulse, respiratory rate and depth, alertness and orientation; [admitted that BP and pulse were not observed, but denies that respiratory rate and depth, alertness and orientation were not observed] (b) check for signs of overdose from the fentanyl 6-8 hourly; [not admitted] (c) report any changes in Patient A's state of alertness and orientation to the practitioner immediately. [Denied] 4. The practitioner failed to order or arrange for appropriate medical tests to be conducted prior to prescribing fentanyl to Patient A including: (a) blood count; [admitted] (b) renal function; [admitted] (c) liver function. [admitted] 5. Between the time the practitioner prescribed Fentanyl to Patient A on 18 February 2015 and 22 February 2015, the practitioner failed to conduct any follow-up consultation with Patient A which he should have done due to the high content of fentanyl in the 50mcg/h patch. [Admitted: practitioner states he verbally directed the nursing staff to advise him of any issue concerning Patient A as was the standard procedure at the facility] 6. On 23 February 2015, after the practitioner noted that Patient A had been unconscious for two days and unresponsive, the practitioner failed to conduct an adequate clinical assessment of Patient A in that he did not: (a) perform a comprehensive medical examination including ordering blood tests; [admitted] (b) consider differential diagnoses for Patient A, including opiate overdose, other than "stroke"; [not admitted] (c) assess the exact level of Patient A's narcosis by performing a naloxone challenge. [Not admitted] 7. On 23 February 2015, after the practitioner noted that Patient A had been unconscious for two days and unresponsive, the practitioner prescribed further medications to Patient A, including morphine 2.5mg subcutaneous (4th hourly), midazolam 25mg (2-4 hourly) and glycopyrrolate (200mg) for Patient A which were not clinically indicated in circumstances where: (a) the practitioner had not assessed Patient A's narcosis by performing a naloxone challenge; [admits that he prescribed such listed medications but denies they were not clinically indicated] (b) the combination of the medications in light of the residual influence from the fentanyl patch put Patient A at risk of respiratory depression and cardiac arrest; [admitted] (c) there was no definitive diagnosis of a terminal illness; [admitted] (d) Patient A had shown a significant and serious decline after being administered narcotics for pain. [admitted]
RESPONDENT'S REPLY
COMPLAINT 2
THE EVIDENCE
Dr Duncan's Report
Dr Kertesz Report.
Evidence of practitioner
FINDINGS
Observations
CONSIDERATION
The Practitioner
Comment
Orders
I hereby certify that this is a true and accurate record of the reasons for decision of the Civil and Administrative Tribunal of New South Wales. Registrar Amendment : 29 March 2018, Annexure A
ANNEXURE A The following conditions are imposed on the practitioner's registration: 1: Within 21 days of the expiration of the suspension period the practitioner is to nominate a registered medical practitioner to act as his professional supervisor for approval by the Medical Council of NSW ("the Council") in accordance with the Medical Council of NSW's Compliance Policy - Supervision Category C (as varied from time to time). 2: The practitioner is: (1) To participate in meetings with the Council-approved supervisor monthly or as varied by the Council. (2) To authorise the Council to provide the proposed and approved supervisor with: (a) A copy of this decision. (b) A copy of these practice conditions. (3) To authorise the supervisor to inform the Council (in an approved reporting format) on a monthly basis that these meetings have occurred, and ensure that the supervisor does in fact provide those reports. (4) To authorise the supervisor to inform the Council immediately if the relationship ends or of any concerns regarding the performance of the practitioner or his compliance with any conditions on his registration. (5) To be supervised for a minimum period of one year from the expiration of the suspension period and as subsequently determined by the Council. (6) To otherwise comply with the Medical Council of NSW's Compliance Policy - Supervision Category C (as varied from time to time). 3: The practitioner shall within 12 months of the expiration of the suspension period: (1) Undertake a course held by the University of Sydney headed "Opioid Treatment Accreditation Course" and provide evidence in writing to the Council of his successful completion of the course. (2) Undertake a course known as GPCE ALM related to the timely diagnosis and improved management of dementia. (3) Complete the following E-Learning modules: AFP Clinical Challenge, April 2015. E-Learning: E77165 Aged Care: Managing Elderly Patients In Primary Care; E-Learning: E97634: Management of Chronic Non-Cancer Pain In Older Patients; E-Learning: E75558 AVANT WEBINAR: Proscribing Perils - Opioids, polypharmacy and Medication Errors. 4: If any course specified in Condition 3 is unavailable then the practitioner is to complete an equivalent course as approved by the Council. 5: All costs associated with completing courses as set out in Condition 3 are to be met by the practitioner.
I hereby certify that this is a true and accurate record of the reasons for decision of the Civil and Administrative Tribunal of New South Wales. Registrar
Amendments 29 March 2018 - Amendment to Annexure A Conditions DISCLAIMER - Every effort has been made to comply with suppression orders or statutory provisions prohibiting publication that may apply to this judgment or decision. The onus remains on any person using material in the judgment or decision to ensure that the intended use of that material does not breach any such order or provision. Further enquiries may be directed to the Registry of the Court or Tribunal in which it was generated. Decision last updated: 29 March 2018
Health Care Complaints Commission
Rahman